Cargando…

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma

Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells are effective treatment for B-cell lymphoma but often cause neurologic toxicity. We treated 20 patients with B-cell lymphoma on a phase I, first-in-humans clinical trial of T cells expressing the novel anti-CD19 CAR Hu19-CD828Z (NCT0265994...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brudno, Jennifer N., Lam, Norris, Vanasse, Danielle, Yueh-wei, Shen, Rose, Jeremy J., Rossi, John, Xue, Allen, Bot, Adrian, Scholler, Nathalie, Mikkilineni, Lekha, Roschewski, Mark, Dean, Robert, Cachau, Raul, Youkharibache, Philippe, Patel, Rashmika, Hansen, Brenna, Stroncek, David F., Rosenberg, Steven A., Gress, Ronald E., Kochenderfer, James N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781235/ https://www.ncbi.nlm.nih.gov/pubmed/31959992 http://dx.doi.org/10.1038/s41591-019-0737-3

Ejemplares similares

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
por: Faruqi, Aiman J., et al.
Publicado: (2022)

Using iCn3D and the World Wide Web for structure-based collaborative research: Analyzing molecular interactions at the root of COVID-19
por: Youkharibache, Philippe, et al.
Publicado: (2020)

Long-term outcomes following CAR T cell therapy: what we know so far
por: Cappell, Kathryn M., et al.
Publicado: (2023)

Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
por: Lam, Norris, et al.
Publicado: (2020)

Author Correction: Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
por: Lam, Norris, et al.
Publicado: (2020)

Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion
por: Jacoby, Elad, et al.
Publicado: (2015)

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
por: Lontos, Konstantinos, et al.
Publicado: (2022)

Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products
por: Shao, Lipei, et al.
Publicado: (2022)

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions
por: Lam, Norris, et al.
Publicado: (2023)

Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
por: Thakur, Archana, et al.
Publicado: (2021)

CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
por: Li, Nan, et al.
Publicado: (2021)

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
por: Agarwalla, Pritha, et al.
Publicado: (2022)

Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells
por: Dreyzin, Alexandra, et al.
Publicado: (2022)

Cable‐Car Electrocatalysis to Drive Fully Decoupled Water Splitting
por: Long, Yuanzheng, et al.
Publicado: (2023)

Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
por: Hu, Biliang, et al.
Publicado: (2017)

Central nervous system prophylaxis in diffuse large B-cell lymphoma: a race to the bottom
por: Roschewski, Mark
Publicado: (2021)

Preventing central nervous system spread in diffuse large B-cell lymphoma – novel approaches needed
por: Roschewski, Mark
Publicado: (2021)

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
por: Jiang, Hua, et al.
Publicado: (2017)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL
por: Fry, Terry J., et al.
Publicado: (2017)

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
por: Scholler, Nathalie, et al.
Publicado: (2022)

Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy
por: Shao, Lipei, et al.
Publicado: (2022)

Topological and Structural Plasticity of the Single Ig Fold and the Double Ig Fold Present in CD19
por: Youkharibache, Philippe
Publicado: (2021)

The IgG4 hinge with CD28 transmembrane domain improves V(H)H-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer
por: Li, Nan, et al.
Publicado: (2023)

In Situ Programming of CAR T Cells
por: Parayath, Neha N., et al.
Publicado: (2021)

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
por: Watanabe, Keisuke, et al.
Publicado: (2023)

Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control
por: Cai, Yihua, et al.
Publicado: (2021)

Universal CARs, universal T cells, and universal CAR T cells
por: Zhao, Juanjuan, et al.
Publicado: (2018)

Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms
por: Lu, Zhongpeng, et al.
Publicado: (2019)

Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
por: Casucci, Monica, et al.
Publicado: (2018)

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
por: Kueberuwa, Gray, et al.
Publicado: (2017)

Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products
por: Lu, Alex, et al.
Publicado: (2020)

Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias
por: Voynova, Elisaveta, et al.
Publicado: (2022)

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
por: Boyiadzis, Michael M., et al.
Publicado: (2018)

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma
por: Xu, Xueer, et al.
Publicado: (2023)

Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion
por: Nussenblatt, Veronique, et al.
Publicado: (2021)

Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion
por: Nussenblatt, Veronique, et al.
Publicado: (2021)

CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0lr2hduqch64u1fm68vrp4le3b